Employee Navigator Announces Acquisition of Ease

Employee Navigator, the leading benefits administration and HR software solution for insurance brokers and employers, today announced the acquisition of Ease, the leading broker centric HR and benefits software solution for small businesses.

Read More

Study Finds Half Of Cash Prices Below Commercial Rates In More Than 2,000 Hospitals

Cash prices for certain hospital services were lower than the average insurance rate in nearly half of the facilities examined in a new study, which could influence rate negotiations between payers and providers.

Read More

U.S. Patients Blindsided By Telehealth Appointments That Charge A Facility Fee

U.S. patients are being blindsided by telehealth costs and many are facing facility fees even though they haven't stepped foot in a hospital or physician's office, The Washington Post reported April 1.

Read More

What Lies Ahead for ACA’s Preventive Care Coverage Mandate?

On March 30, a single federal judge in Texas struck down a provision of the Affordable Care Act (ACA) that required free coverage for a host of preventive health services for people with private insurance. Under this decision, private health plans are no longer required to cover certain cancer screenings, services or medications to prevent heart disease, or perinatal depression preventive interventions, among others, with no cost sharing.

Read More

Medi-Cal Will Soon End Some People’s Benefits. What This Means For You

Since the COVID-19 pandemic began in earnest, low-income Californians who enrolled in Medi-Cal — California’s version of the government-funded Medicaid health insurance program — have been able to keep their coverage without having to prove every year that they still qualified for it. That’s because the Families First Coronavirus Response Act, which President Trump signed ...

Read More

HHS Quietly Trims Inaugural List Of Price Capped Medicare Drugs From 27 To 20

The Department of Health and Human Services’ (HHS’) highly publicized list of the first Medicare Part B prescription drugs hit with rebates under the Inflation Reduction Act discreetly dropped from 27 to 20, prompting critiques from the pharma lobby over the Biden administration’s swift implementation of the legislation’s drug controls. As spotted by Endpoints, the press release and ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square